News Focus
News Focus
icon url

JJPow

12/15/19 6:00 PM

#234234 RE: Jamaalish #234233

30-50% bad experience? Where do you get those numbers from?
icon url

Jamaalish

12/15/19 6:01 PM

#234235 RE: Jamaalish #234233

Maybe I should adjust those figures down some, because there were also some where it was more a problem of affordability.

icon url

Retiredceo

12/15/19 6:02 PM

#234237 RE: Jamaalish #234233

What a load of BS. Go away.
icon url

BioBS2012

12/15/19 6:08 PM

#234240 RE: Jamaalish #234233

If you can’t support what you say with something solid, please don’t post rubbish.
You can keep your 2 cents.
icon url

Invest83838

12/15/19 6:37 PM

#234265 RE: Jamaalish #234233

Jamaal, Shorts Hate Vascepa and Longs Love Vascepa

so it is true that it is a love / hate thing

at least from an investment viewpoint :-)))
icon url

amarinbullfromchicago

12/15/19 6:55 PM

#234271 RE: Jamaalish #234233

Read the reduce it results. The sides and positives. That’s 8100 over 5 years. Good compliance. There is absolutely no reason this would cause joint pain. It’s an anti inflammatory- should be used to help joint pain before it would cause it haha
icon url

AnotherInvestor

12/15/19 8:09 PM

#234293 RE: Jamaalish #234233

It's not justifiable to make up statistics. We don't know if you're shorting the stock.
icon url

biowreck

12/15/19 8:21 PM

#234301 RE: Jamaalish #234233

Jama...you sure your not confusing V with Lovaza? I know several people on V...no issues but great lipid numbers!